Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women; A 2 year, placebo-controlled study

G.W. de Valk-Roo, C.D.A. Stehouwer, P. Meijer, V. Mijatovic, C. Kluft, P. Kenemans, F. Cohen, S. Watts, C. Netelenbos

Research output: Contribution to journalArticleAcademicpeer-review

16 Downloads (Pure)
Original languageEnglish
Pages (from-to)2993-3000
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume19
Issue number12
DOIs
Publication statusPublished - 1999

Cite this